Scandius BioMedical
Littleton, Colorado, United States
About Scandius BioMedical
Scandius BioMedical develops tissue/bone fixation products for the orthopaedic sports medicine market. Their product offering includes STRATIS ST, a femoral fixation system that enables surgeons to perform soft tissue anterior cruciate ligament reconstruction arthroscopically; TriTis, a soft tissue tibial fixation device.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $12.0M
- Funding stage: M&A
- Last round: Series C (Feb 2005)
- Website: scandius.com
Industries & Categories
Biotechnology, Health Care, Medical
Canonical: https://fsome.com/organization/scandius-biomedical-2602635 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.